Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting

Press/Media

Period	30 Sep 2024

Media coverage

Title	Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting
Media name/outlet	WICZ
Country/Territory	United States
Date	30/09/24
URL	ct.moreover.com/?a=54906026272&p=1gw&v=1&x=O1YKY6C4cGxFk955PRdrvw
Persons	Mark Lebwohl